MRUS - Merus gets FDA breakthrough therapy status for petosemtamab
2024-05-13 12:47:21 ET
More on Merus
- Merus: Positive Zenocutuzumab Data In 2024 Could Provide BLA Advancement
- FDA accepts Merus application for Zeno for lung, pancreatic cancer
- Gilead to invest in Merus as part of a research deal
- Seeking Alpha’s Quant Rating on Merus
- Historical earnings data for Merus